by In2Pharma | Jun 11, 2020 | News
Belgium Marketing authorisation holders of a medicinal product for human use are required to follow certain guidelines for the labelling and packaging of medicinal products. These guidelines (“Labelling of medicinal products” ) have recently been updated. The main...
by In2Pharma | Jun 11, 2020 | News
The Netherlands The Medicines Evaluation Board (MEB) recently revised 2 policy documents relating to the requirements for product information: “labelling of pharmaceutical products” and “Nomenclature of pharmaceutical products”. The revision only applies to medicinal...
by In2Pharma | Sep 24, 2019 | News
Belgium As from 1 May 2019, new Belgian rules apply to the harmonisation of SPC, labelling and patient information leaflet. The FAMHP clarifies the rules for harmonisation of SPC’s, labelling and patient information leaflets (PIL) in different countries. Marketing...
